Ordinary Re-Weighting | Solactive EU Pharma Index | Effective Date 3rd April 2024
Solactive EU Pharma Index:
In the ordinary re-weighting, the following composition will be implemented effective open 3rd April 2024:
| ALMIRALL SA |
| ASTRAZENECA PLC |
| BAYER AG |
| EUROAPI SAS |
| GALAPAGOS NV |
| GENMAB A/S |
| GSK PLC |
| HIKMA PHARMACEUTICALS PLC |
| HALEON PLC |
| H LUNDBECK AS – Class B |
| IPSEN SA |
| LONZA GROUP AG |
| MORPHOSYS AG |
| MERCK KGAA |
| NOVARTIS AG |
| NOVO NORDISK A/S |
| ORION OYJ CLASS B |
| RECORDATI SPA |
| ROCHE HOLDING AG |
| SANOFI SA |
| SWEDISH ORPHAN BIOVITRUM AB |
| UCB SA |